George Chkhenkeli

Barbara Sloan1
Rollie E. Ronquillo1
1Barbara Sloan
1Rollie E. Ronquillo
1Cheryl A. Stoddart
Learn More
  • Cheryl A. Stoddart, Cheryl A. Bales, Jennifer C. Bare, George Chkhenkeli, Sofiya A. Galkina, April N. Kinkade +5 others
  • 2007
BACKGROUND The SCID-hu Thy/Liv mouse model of HIV-1 infection is a useful platform for the preclinical evaluation of antiviral efficacy in vivo. We performed this study to validate the model with representatives of all four classes of licensed antiretrovirals. METHODOLOGY/PRINCIPAL FINDINGS Endpoint analyses for quantification of Thy/Liv implant viral(More)
  • 1